abstract |
The present invention relates to phenalkylamine derivatives of the formula (I) or (II) n n n n n n n n n n or a physiologically tolerated salt thereof. n The invention relates to pharmaceutical compositions comprising such phenalkylamine derivatives, and the use of such phenalkylamine derivatives for therapeutic purposes. The phenalkylamine derivatives are GlyT1 inhibitors. |